MENU
IGMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

IGM Biosciences (IGMS) Earnings Date & Reports

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

A.I. Advisor
published Earnings

IGMS is expected to report earnings to fall 45.85% to -35 cents per share on May 08

IGM Biosciences IGMS Stock Earnings Reports
Q1'25
Est.
$-0.35
Q4'24
Beat
by $0.08
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.75
Q1'24
Missed
by $0.02
The last earnings report on March 27 showed earnings per share of -64 cents, beating the estimate of -73 cents. With 37.83K shares outstanding, the current market capitalization sits at 73.52M.
View a ticker or compare two or three
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com